Trials / Completed
CompletedNCT01505387
Litramine in Weight Maintenance
Double-blind, Randomized, Placebo-controlled Clinical Investigation to Evaluate the Safety and Efficacy of Litramine in Maintaining Body Weight Loss in Overweight and Obese Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The effect of Litramine on weight loss has previously been studied during a 12-week intervention period with promising results. The present study looks into the effect of weight maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Litramine | Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal) |
| DIETARY_SUPPLEMENT | Placebo | Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal) |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-01-06
- Last updated
- 2015-06-01
- Results posted
- 2015-04-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01505387. Inclusion in this directory is not an endorsement.